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Abstract. The aim of the study was to compare the ex- 
tent and severity of reversible underperfusion i silent 
versus painful myocardial ischaemia during the dobuta- 
mine stress test. A consecutive series of 85 patients with 
significant coronary artery disease and reversible perfu- 
sion defects on technetium-99m ethoxyisobutylisoni- 
trile single-photon emission tomography performed at 
rest and during high-dose dobutamine stress (up to 40 gg 
kg q min 1) were studied. The left ventricle was divided 
into six segments. An ischaemic perfusion score was de- 
rived quantitatively by subtracting the rest from the 
stress defect score. Patients with multivessel disease had 
a higher ischaemic score (610_762 vs 310_411, P<0.05) 
and a higher number of reversible perfusion defects 
(2.1_+1.2 vs 1.1_+0.8, P<0.01) than patients with single- 
vessel disease. Typical angina occurred in 37 patients 
(44%) during the test. There was no significant differ- 
ence between patients with and patients without angina 
with respect o age, gender, peak rate-pressure product, 
prevalence of previous myocardial infarction, diabetes 
mellitus, multivessel disease or number of stenotic oro- 
nary arteries. Stress, rest and ischaemic scores as well as 
the number and distribution of reversible defects were 
not different in patients with and patients without angi- 
na. Patients with angina more frequently had a history of 
typical angina before the test (43% vs 17%, P<0.01) and 
ST-segment depression during the test (54% vs 25%, 
P<0.01). It is concluded that in patients with coronary 
artery disease and ischaemia detected by dobutamine 
scintigraphy, the extent and severity of coronary artery 
disease and myocardial perfusion abnormalities are simi- 
lar with or without angina during stress testing. 
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Introduction 
Pharmacological stress testing with dobutamine is in- 
creasingly used for non-invasive diagnosis and evalua- 
tion of coronary artery disease in patients with suspected 
myocardial ischaemia nd inadequate xercise capacity 
[1-8]. The induction of myocardial ischaemia with do- 
butamine infusion is mainly due to an increase in myo- 
cardial contractility and heart rate [9]. Dobutamine has 
also been reported to induce coronary blood flow hetero- 
geneity [10]. Recent studies have shown that dobutamine 
stress testing in conjunction with technetium-99m e- 
thoxyisobutylisonitrile (MIBI) or thallium-201 single- 
photon emission tomographic (SPET) imaging is an ac- 
curate method for the diagnosis and localization of myo- 
cardial ischaemia nd coronary artery disease based on 
the detection of reversible underperfusion [3-8]. The lat- 
ter was shown to be more sensitive than angina and ST- 
segment depression [3-8]. However, the extent and se- 
verity of dobutamine-induced underperfusion have not 
been compared in the presence or absence of concomi- 
tant angina. Since recent studies have shown that the ex- 
tent and severity of exercise-induced underperfusion 
have an impact on the prognosis [11, 12], identification 
of stress test variables associated with more severe per- 
fusion abnormalities is a clinically relevant issue. There- 
fore, the aim of this study was to assess the extent and 
severity of dobutamine-induced perfusion abnormalities 
with or without angina during dobutamine stress testing 
in patients with coronary artery disease. 
Materials and methods 
Patient population. The study population was derived from a con- 
secutive series of patients with limited exercise capacity referred 
to the nuclear imaging laboratory of our centre for diagnostic 
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evaluation of myocardial ischaemia. All patients underwent dobu- 
tamine stress testing in conjunction with 99mTc-MIBI SPET. 
Eighty-five patients were included according to the following cri- 
teria: (1) significant coronary artery disease defined as >50% di- 
ameter stenosis of >_1 major epicardial artery; (2) the occurrence 
of myocardial ischaemia during the test, defined as reversible per- 
fusion defects on MIBI SPET in the distribution of >1 stenotic 
coronary artery; (3) absence of left ventricular hypertrophy or left 
bundle branch block. Mean age was 60+-10 years; 61 patients 
(72%) were males. A history and/or electrocardiographic evidence 
of a previous myocardial infarction were present in 47 patients 
(55%). A history of typical effort angina before the test was ob- 
tained in 24 patients (28%). On the day of the test, 65 patients 
(76%) were receiving anti-anginal medication, including beta 
blocker therapy in 44 cases (52%). 
The patients were selected from among 125 patients with sig- 
nificant coronary artery disease with or without ischaemia on do- 
butamine MIBI study. Thus, the prevalence of a positive dobuta- 
mine MIBI study was 68% in our series of patients. Among the 40 
patients with significant coronary artery disease and without isch- 
aemia detected by dobutamine MIBI SPET, angina occurred in 14 
(35%) during the test. 
Dobutamine stress test. Dobutamine was infused through an ante- 
cubital vein starting at a dose of 5 gg kg -1 rain -1 for 3 rain, then at 
10 gg kg -1 rain -1 for 3 rain, and increasing by 10 ~tg kg 1 min-1 
every 3 rain to a maximum of 40 gg kg -1 rain -~. Atropine (up to 
1 rag) was given in patients not achieving 85% of their age-pre- 
dicted maximal heart rate [5]. The electrocardiogram was moni- 
tored throughout dobutamine infusion and recorded each minute. 
Cuff blood pressure was measured every 3 rain. Significant ST- 
segment depression was defined as 21 mm horizontal or down- 
sloping depression 80 ms after the J point, below the resting base- 
line level. The test was interrupted if severe chest pain, ST-seg- 
ment depression >2 ram, ST-segment elevation >2 mm in patients 
without previous myocardial infarction [13], significant ventricu- 
lar or supraventricular t chyarrhythmia or a fall in systolic blood 
pressure of >40 mmHg occurred uring the test. 
MIBI SPET imaging. Approximately 1 rain before the termination 
of the stress test, an intravenous dose of 370 MBq of MIBI was 
administered. The acquisition of stress SPET images was started 
1 h after MIBI injection. For the resting MIBI studies, 370 MBq 
was injected at least 24 h after the first study. Image acquisition 
and interpretation were performed according to a previously de- 
scribed protocol [5]. The left ventricular images were divided into 
six segments: anterior, septal (subdivided into the anterior and 
posterior septum), lateraI, inferoposterior and apical. A persistent 
perfusion defect on both stress and rest imaging was classified as 
a fixed defect. A reversible defect was defined as a perfusion de- 
fect on stress images that partially or completely resolved at rest 
imaging. This was considered diagnostic of ischaemia. An experi- 
enced observer, unaware of patients' clinical and angiographic da- 
ta, reviewed the images. The interpretation was semiquantitatively 
performed by visual analysis assisted by circumferential profile 
analysis. Each of the six left ventricular segments was scored on a 
four-grade classification where 0 = normal and 3 = severely re- 
duced or absent uptake. The visual perfusion defect score was de- 
rived by the summation of the score of the six myocardial seg- 
ments for both rest and stress imaging. The difference between the 
stress and rest scores (ischaemic score) was considered represen- 
tative of the total amount of stress-induced underperfusion. The 
perfusion defect score was quantitatively calculated at rest and at 
stress imaging by measuring the area between the lower limit of 
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normal values (+-2 SD) and the actual circumferential profile in six 
short-axis lices. 
Quantitative coronal 7 angiography. All patients underwent coro- 
nary angiography within 3 months of dobutamine stress testing. 
Coronary lesions were quantified using a previously described 
method from our centre [14]. 
Statistical analysis. Unless specified, data are presented as mean 
values _+SD. The chi square test and Fisher exact est were used to 
compare differences between proportions. Student's t test was 
used for analysis of continuous data. A P value <0.05 was consid- 
ered statistically significant. 
Results 
Haemodynamic response 
Heart rate increased from 68_+13 to 132_+17 beats/rain at 
peak stress (P<0.0001) and systolic blood pressure from 
133+21 to 146+31 mmHg (P<0.01). Atropine was ad- 
ministered in 37 (44%) patients (mean dose = 0.6 rag). 
In 16 patients, the test was interrupted prematurely be- 
fore reaching the maximal  dose or the target heart rate. 
Reasons for premature termination of  the test were angi- 
na in ten patients, ST-segment depression in three pa- 
tients, hypotension in one patient and tachyarrhythmia in 
two patients. ST-segment depression occurred in 32 
(38%). Thirty-seven patients (44%) developed typical 
angina during the test (symptomatic  ischaemia group). 
The remaining 48 patients (56%) without angina during 
the test constituted the silent ischaemia group. 
Demographic, haemodynamic and angiographic 
characteristics (Table 1) 
There was no signif icant difference between patients 
with and patients without angina with respect to age, 
gender, prevalence of previous myocardia l  infarction, di- 
abetes mell itus, hypertension or smoking. A history of 
typical effort angina was encountered more frequently in 
patients with angina during the test. Peak heart rate was 
signif icantly lower in patients with angina, whereas peak 
rate pressure product was not signif icantly different in 
the two groups. ST-segment depression occurred in 20 of 
37 patients with and in 12 of 48 patients without angina 
(54% vs 25%, P<0.01). Prevalence of mult ivessel dis- 
ease, number of  coronary arteries with signif icant steno- 
sis, percentage diameter of the most severe stenosis and 
distribution of individual coronary artery stenoses were 
not signif icantly different between the two groups. 
MIBI SPET results (Table 2) 
There was no signif icant difference between patients 
with and patients without angina with respect to the 
number of myocardia l  segments with reversible defects, 
segments with perfusion defects on rest imaging, stress 
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Table 1. Clinical and angiographic data of 
patients with coronary artery disease and 
reversible perfusion defects with and with- 
out angina during dobutamine stress testing 
Angina (n=37) Silent (n=48) 
Age (years) 
Male gender 
Beta blocker therapy 
History of angina pectoris 
Previous myocardial infarction 
Diabetes mellitus 
Multivessel disease 
Number of stenotic arteries 
% diameter of most severe stenosis 
>90% diameter stenosis in _>1 artery 
Peak heart rate (beats/rain) 
Peak systolic blood pressure (mmHg) 
Peak rate pressure product 
Peak dobutamine dose (btg kg -I min -l) 
60+10 59_+11 
26 (70%) 35 (73%) 
22 (59%) 22 (46%) 
16 (43%) 8 (17%)* 
19 (51%) 28 (58%) 
4 (11%) 6 (13%) 
18 (49%) 22 (46%) 
1.7_+0.8 1.7.+0.9 
85%_+16% 90_+11% 
28 (75%) 39 (84%) 
126_+17 137_+19" 
156_+32 138_+31" 
19,633_+4,287 19,003+4,845 
40_+0 39_+4 
* P<0.01 
Table 2. Scintigraphic data of patients with coronary artery dis- 
ease and reversible perfusion defects with and without angina dur- 
ing dobutamine stress testing 
Angina (n=37) Silent (n=48) 
Stress core 7.1_+3.1 7.8+3.2 
Rest score 3.5_+2.0 4.0_+2.3 
Ischaemic score 3.2_+1.6 3.9_+2.3 
Number of reversible defects 1.6_+0.8 1.9_+0.9 
Number of fixed defects 1.2_+ 1.0 1.2_+ l.1 
on rest imaging 
Quantitative stress defect 1,426_+1737 1,251_+1354 
Quantitative r st defect 1,063_+1498 825_+965 
Quantitative ischaemic defect 472_+630 458_+671 
Table 3. Distribution of reversible perfusion defects in the six ma- 
jor left ventricular segments in patients with and patients without 
angina during dobutamine stress testing 
Angina (n=37) Silent (n=48) 
Anterior 10 (27%) 15 (31%) 
Septal anterior 8 (22%) 13 (27%) 
Septal posterior 8 (22%) 11 (23%) 
Inferoposterior 22 (59%) 28 (58%) 
Lateral 5 (14%) 8 (17%) 
Apex 6 (16%) 15 (31%) 
Values are expressed as number and percentage (%) of patients 
with reversible perfusion defects in the specified region 
perfusion defect score, rest score or ischaemic score by 
both visual and quantitative analysis. Exclusion of pa- 
tients in whom the test was interrupted prematurely did 
not alter the comparable xtent and severity of underper- 
fusion with or without angina. The regional distribution 
of reversible defects was not different in the two groups 
(Table 3). 
The perfusion scan of a patient with left anterior de- 
scending and right coronary artery stenosis and a revers- 
ible perfusion defect on dobutamine MIBI scintigraphy 
without angina or ST-segment depression during the test 
is shown in Fig. 1. 
Patients with ST-segment depression 
There was no significant difference between patients 
with and patients without ST-segment depression with 
respect o total number of reversible defects (1.8_+1.0 vs 
1.7_+0.9) or quantitative ischaemic score (Table 4). Re- 
versible perfusion defects without angina or ST-segment 
depression occurred in 36 patients (42%), whereas a 
combination of angina and ST-segment depression oc- 
curred in 20 patients (23%). The quantitative ischaemic 
score was not different in the groups with various com- 
binations of angina and ST-segment depression (Table 
4). 
Extent and severity of ischaemia in single-vessel versus 
multivessel disease 
Patients with multivessel disease (n=40) had a signifi- 
cantly higher number of reversible perfusion defects 
(2.1+1.2 vs 1.1_0.8, P<0.01), a significantly higher vi- 
sual ischaemic score (4.7_2.5 vs 2.6+1.9, P<0.01) and a 
significantly higher quantitative ischaemic score 
(610_+762 vs 310_+411, P<0.05) than the 45 patients with 
single-vessel disease (Fig. 2). 
Discussion 
Evaluation of the extent and severity of reversible perfu- 
sion defects during stress testing is important for prog- 
nostic stratification of patients with coronary artery dis- 
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Table 4. Quantitative ischaemic perfusion defect score in patients 
with different combinations of angina and ST-segment depression 
during dobutamine stress testing 
Yes No 
ST depression 508_+680 430_+479 
(32 pts) (53 pts) 
Combined ST depression 441+614 465_+679 
and angina (20 pts) (65 pts) 
ST depression 534_+699 402+571 
and/or angina (49 pts) (36 pts) 
pts, Patients 
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Fig. 2. Ischaemic perfusion defect score derived by quantitative 
analysis of the circumferential profile in patients with single-, 
two- and three-vessel disease (VD),showing a positive correlation 
between the d fect extent and severity and number of stenotic cor- 
onary arteries 
Fig. 1. a Dobutamine stress (l@) and rest (right) MIBI perfusion 
scintigraphic mages of a 55-year-old male with significant steno- 
sis of the left anterior descending and rightcoronary arteries, from 
the apical short-axis level (the uppermost images are more apical). 
On the dobutamine stress images a large perfusion defect is ob- 
served in the posteroinferior wall (vertical arrows), and a small 
defect in the septum (horizontal rrows); these defects were 
shown to be reversible on the rest images, b Corresponding cir- 
cumferential profile analysis. The patient had no symptoms or 
electrocardiographic changes during the test. ANT/A, Anterior; 
SEP/S, septum; POS/P, posterior; LAT/L, lateral. 1-2 is a clock- 
wise division of the segments in the short-axis slices. EX, Stress; 
RE, rest; LL, lower limit 
dates the use of perfusion scintigraphy in the assessment 
of the extent of myocardial ischaemia. 
Our results show that in patients with significant cor- 
onary artery disease and myocardial ischaemia detected 
by dobutamine perfusion scintigraphy, the extent and se- 
verity of coronary artery disease and reversible under- 
perfusion do not differ according to whether angina is or 
is not present during the test. Parameters of reversible 
underperfusion were also similar in patients who had 
both angina nd ST-segment depression and in patients 
without this combination. Apart from a higher preva- 
lence of a history of typical angina in symptomatic pa- 
tients during the test, clinical characteristics were not 
different in patients with and patients without angina 
during the dobutamine stress test. 
ease [ 11, 12]. In our study, the additional value of angina 
and/or ST-segment depression in patients with coronary 
artery disease and dobutamine-induced ischaemia mani- 
fested as reversible perfusion defects on MIBI SPET was 
evaluated. Our finding of a higher number of reversible 
perfusion defects and a higher ischaemic score in pa- 
tients with multivessel versus single-vessel disease vali- 
Comparison with previous studies 
To our knowledge, this is the first study in which the ex- 
tent and severity of underperfusion i silent and symp- 
tomatic ischaemia during dobutamine stress testing have 
been evaluated. Discordant results have been published 
on the functional significance of silent versus symptom- 
atic ischaemia during exercise stress testing [15-20]. Re- 
European Journal of Nuclear Medicine Vol. 23,No. 10, October 1996 
1358 
versible exercise-thallium defects were reported to be 
more extensive and severe in patients with compared to 
those without angina in the studies of Klein et al. [15] 
and Travin et al. [16], while others failed to demonstrate 
such a difference [17-20]. Klein et al. [15] concluded 
that the induction of pain is associated with substantially 
more functional abnormalities when patients with a 
broad spectrum of coronary artery disease are evaluated. 
They indicated that chest pain tends to lose its apparent 
value when its analysis is restricted to a coronary artery 
disease population with a greater pre-test likelihood of 
manifesting ischaemia. 
Studies of left ventricular function 
Various studies have compared the amount of abnormal- 
ly contracting myocardium in silent and painful isch- 
aemia during exercise stress testing using radionuclide 
ventriculography [21-23] or echocardiography [24-26]. 
Iskandrian and Hakki [21] and recently Nihoyannopolos 
et al. [26] reported that angina correlated with more se- 
vere deterioration of regional function. Other studies 
have demonstrated a comparable segmental and global 
exercise-induced left ventricular dysfunction in silent 
and symptomatic schaemia evaluated by exercise radio- 
nuclide ventriculography [22, 23] or echocardiography 
[24, 25]. We have recently shown that in patients with 
coronary artery disease, the extent and severity of dobu- 
tamine-induced left ventricular dysfunction assessed by 
echocardiography do not differ in patients with and pa- 
tients without angina [27]. The results of this scinti- 
graphic study confirm our previous findings. Although 
stress-induced wall motion abnormalities are highly spe- 
cific for myocardial ischaemia, this study offers the fol- 
lowing complementary advantages: (1) the quantitative 
assessment of perfusion compared to the visual semi- 
quantitative chocardiographic assessment of wall mo- 
tion; (2) the ability of perfusion scintigraphy to detect 
ischaemia in akinetic segments; (3) the less operator-de- 
pendent characteristics of the perfusion imaging tech- 
nique; (4) the higher sensitivity of perfusion scintigra- 
phy as compared with echocardiography at submaximal 
stress [28]. 
Haemodynamic and electrical response 
Our results demonstrate a slightly lower peak heart rate 
in patients with angina and a comparable peak rate-pres- 
sure product. This may be attributed to early interruption 
of the test in t 8 patients because of angina. However, ex- 
clusion of patients in whom the test was terminated pre- 
maturely did not alter the comparable parameters of un- 
derperfusion i  patients with and patients without angi- 
na. The lower peak heart rate in patients with angina is 
consistent with previous reports on exercise [15, 20] and 
dobutamine stress testing [27]. ST-segment depression 
occurred more frequently in the symptomatic group. A 
higher prevalence of electrically silent ischaemia in 
asymptomatic patients has been reported uring dobuta- 
mine [27] and exercise stress testing as well [17, 20, 25], 
which may suggest acommon pathway for both the elec- 
trocardiographic and the pain response to ischaemic 
stimulus [20]. 
ST-segment depression and the amount of ischaemia 
In this study, the extent and severity of reversible under- 
perfusion during dobutamine stress testing did not differ 
in patients with and patients without ST-segment depres- 
sion. We have previously reported a similar ischaemic 
wall motion score with or without ST-segment depression 
during dobutamine stress testing, and a higher number of 
ischaemic segments with normal baseline contraction in 
patients with ST-segment depression. However, in the 
present study we failed to identify a corresponding differ- 
ence in number of segments with a completely reversible 
defect in patients with and patients without ST-segment 
depression. This contradiction may be explained by the 
fact that a partially reversible defect may represent isch- 
aemia in the absence of baseline wall motion abnormali- 
ties. Additionally, in patients with myocardial infarction 
and stress-induced ST-segment elevation, concomitant 
ST-segment depression may represent reciprocal changes 
without rue ischaemia. Hecht et al. [20] and Mahmarian 
et al. [19] reported that in patients with coronary artery 
disease, positive and negative exercise electrocardio- 
graphic findings were associated with a similar amount 
of ischaemia on exercise thallium scintigraphy. Converse- 
ly, Hecht et al. [25] concluded that exercise-induced ST- 
segment depression is the single most significant variable 
in relation to the amount of ischaemic myocardium as- 
sessed by exercise chocardiography. 
Limitations of the study 
We assessed myocardial ischaemia on basis of reversible 
perfusion defects, which may represent flow malperfu- 
sion as well as true ischaemia. The detection of revers- 
ible perfusion defects in dyssynergic segments may re- 
present a clinical challenge. Another limitation of the 
study is that most of the patients were receiving anti-an- 
ginal medication which may modify symptoms and 
signs of ischaemia. We have previously shown that the 
adminstration of atropine enhances the detection of 
myocardial ischaemia during dobutamine stress testing, 
especially in patients receiving beta blockers [29]. Fur- 
thermore, the percentage of patients receiving medica- 
tions was not different in the two groups. Finally, ST- 
segment depression in patients with myocardial infarc- 
tion may represent reciprocal changes without isch- 
aemia. Despite this limitation, exercise-induced ST-seg- 
ment depression after myocardial infarction has general- 
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ated with an adverse outcome [30]. 
Conclusions 
In patients with coronary artery disease and ischaemia 
manifested as transient perfusion defects on dobutamine 
MIBI SPET imaging, the extent and severity of coronary 
artery disease and reversible underperfusion were com- 
parable in patients with and patients without angina dur- 
ing the test. Patients with symptomatic schaemia had a 
higher prevalence of typical effort angina before the test 
and a higher prevalence of ST-segment depression dur- 
ing the test. The amount of ischaemic myocardium was 
similar in patients with and patients without ST-segment 
depression. The absence of angina and/or ST-segment 
depression during stress testing of patients with anatomi- 
cally and functionally significant coronary artery disease 
was not an indicator of less severe ischaemia. 
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